Beta-adrenergic receptor activation rescues theta frequency stimulation-induced LTP deficits in mice expressing C-terminally truncated NMDA receptor GluN2A subunits.
Through protein interactions mediated by their cytoplasmic C termini the GluN2A and GluN2B subunits of NMDA receptors (NMDARs) have a key role in the formation of NMDAR signaling complexes at excitatory synapses. Although these signaling complexes are thought to have a crucial role in NMDAR-dependent forms of synaptic plasticity such as long-term potentiation (LTP), the role of the C terminus of GluN2A in coupling NMDARs to LTP enhancing and/or suppressing signaling pathways is unclear. To address this issue we examined the induction of LTP in the hippocampal CA1 region in mice lacking the C terminus of endogenous GluN2A subunits (GluN2AΔC/ΔC). Our results show that truncation of GluN2A subunits produces robust, but highly frequency-dependent, deficits in LTP and a reduction in basal levels of extracellular signal regulated kinase 2 (ERK2) activation and phosphorylation of AMPA receptor GluA1 subunits at a protein kinase A site (serine 845). Consistent with the notion that these signaling deficits contribute to the deficits in LTP in GluN2AΔC/ΔC mice, activating ERK2 and increasing GluA1 S845 phosphorylation through activation of β-adrenergic receptors rescued the induction of LTP in these mutants. Together, our results indicate that the capacity of excitatory synapses to undergo plasticity in response to different patterns of activity is dependent on the coupling of specific signaling pathways to the intracellular domains of the NMDARs and that abnormal plasticity resulting from mutations in NMDARs can be reduced by activation of key neuromodulatory transmitter receptors that engage converging signaling pathways.
Interdepartmental PhD Program for Neuroscience, University of California Los Angeles, Los Angeles, California 90024, USA.
Teena D
TD
Moody
Ayako M
AM
Watabe
Tim
T
Indersmitten
Noboru H
NH
Komiyama
Seth G N
SG
Grant
Thomas J
TJ
O'Dell
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D055592:Biophysical Phenomena / Q000235:genetics; D004558:Electric Stimulation / Q000379:methods; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology; D006624:Hippocampus / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D017774:Long-Term Potentiation / Q000187:drug effects / Q000235:genetics* / Q000502:physiology; D051379:Mice; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism; D009154:Mutation / Q000235:genetics*; D016202:N-Methylaspartate / Q000494:pharmacology; D018408:Patch-Clamp Techniques / Q000379:methods; D010446:Peptide Fragments / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D017966:Pyramidal Cells / Q000187:drug effects / Q000502:physiology; D011943:Receptors, Adrenergic, beta / Q000378:metabolism*; D016194:Receptors, N-Methyl-D-Aspartate / Q000172:deficiency / Q000235:genetics; D012694:Serine / Q000378:metabolism
D000318:Adrenergic beta-Agonists; D018690:Excitatory Amino Acid Agonists; D007545:Isoproterenol; D019950:Mitogen-Activated Protein Kinase 1; D016202:N-Methylaspartate; D010446:Peptide Fragments; D011943:Receptors, Adrenergic, beta; D016194:Receptors, N-Methyl-D-Aspartate; D012694:Serine
J Neurosci. 2000 Aug 15;20(16):5924-31
10934239
Nat Rev Neurosci. 2004 Oct;5(10):771-81
15378037
J Neurosci. 2003 May 1;23(9):3679-88
12736339
Nature. 2001 Jun 14;411(6839):801-5
11459059
Neuron. 1996 Sep;17(3):475-82
8816710
PLoS One. 2010 Jul 22;5(7):e11732
20661302
Pharmacol Ther. 2006 Dec;112(3):810-32
16904750
J Biol Chem. 2007 Sep 14;282(37):27527-27535
17635924
J Neurochem. 1997 Aug;69(2):623-30
9231720
Nat Neurosci. 2003 Feb;6(2):136-43
12536214
J Neurosci. 2003 Nov 26;23(34):10791-9
14645471
J Biol Chem. 1999 Sep 24;274(39):27467-73
10488080
Neuron. 1998 Nov;21(5):1151-62
9856470
Neuron. 1998 Nov;21(5):1163-75
9856471
J Neurosci. 2008 Apr 2;28(14):3623-30
18385321
Neurobiol Aging. 2003 Mar-Apr;24(2):267-72
12498960
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4344-51
16537406
Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R225-34
16150739
J Neurosci. 2007 Aug 1;27(31):8334-43
17670980
J Neurosci. 1998 Sep 15;18(18):7118-26
9736635
Neuron. 2008 Jan 24;57(2):248-62
18215622
J Neurosci. 2007 Dec 12;27(50):13843-53
18077696
J Physiol. 2008 Dec 15;586(24):5885-900
18936077
J Neurosci. 2003 Jul 2;23(13):5827-34
12843287
Cell. 1996 Mar 8;84(5):757-67
8625413
Neuron. 2002 Jan 31;33(3):325-40
11832222
Neuron. 1998 Apr;20(4):683-91
9581761
Nat Genet. 2010 Nov;42(11):1021-6
20890276
J Neurosci. 2010 Feb 17;30(7):2676-85
20164351
Neuron. 2007 Nov 21;56(4):670-88
18031684
Neuron. 1999 Nov;24(3):715-26
10595521
Nat Neurosci. 2000 Jul;3(7):661-9
10862698
Curr Opin Neurobiol. 2001 Jun;11(3):327-35
11399431
J Neurosci. 2002 Jun 15;22(12):4860-8
12077183
Neuron. 1998 May;20(5):895-904
9620694
Mol Syst Biol. 2009;5:269
19455133
Neuron. 2005 Oct 20;48(2):289-301
16242409
Neuron. 2005 Jun 2;46(5):745-60
15924861
J Neurosci. 2002 Nov 15;22(22):9721-32
12427827
J Neurosci. 2000 Nov 1;20(21):7880-7
11050107
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3239-44
10077668
Sci Signal. 2009 Apr 28;2(68):ra19
19401593
J Neurosci. 1999 Jun 1;19(11):4337-48
10341237
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15951-6
20733080
Cell Signal. 2010 May;22(5):728-36
20043991
J Neurosci. 2007 Nov 28;27(48):13210-21
18045915
J Neurochem. 2010 Aug;114(4):1107-18
20524968
EMBO J. 2010 Jan 20;29(2):482-95
19942860
J Biol Chem. 2006 Jan 13;281(2):752-8
16272153
Cell. 1998 Jan 23;92(2):279-89
9458051
J Neurosci. 1999 Dec 15;19(24):10603-10
10594044
J Neurosci. 2006 Feb 8;26(6):1721-9
16467520
J Neurochem. 2006 Apr;97 Suppl 1:16-23
16635246
Sci STKE. 2004 Oct 19;2004(255):re16
15494561
J Neurosci. 2007 Mar 7;27(10):2673-82
17344405
Neuron. 2000 Jul;27(1):107-19
10939335
Science. 1995 Sep 22;269(5231):1737-40
7569905
J Neurosci. 2000 Jun 15;20(12):4573-81
10844027
Nature. 1998 Dec 3;396(6710):433-9
9853749
J Neurosci. 2008 Oct 22;28(43):10803-13
18945888